The U.S. Food and Drug Administration seeks to accelerate clinical trials of new medicines by using artificial intelligence to streamline the laborious process of collecting and submitting study data.
About the Author
Discover more from InfoVera USA
Subscribe to get the latest posts sent to your email.
